Clinical experiences with Ro 15-1788 (Anexate) in benzodiazepine and mixed-drug overdoses
β Scribed by R. Fantozzi; L. Caramelli; M. Baraitini; P. Botti; F. Ledda; E. Masini; F. Moroni; S. Peruzzi; A.M. Zorn; P.F. Mannaioni
- Book ID
- 103659507
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 262 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0300-9572
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Noradrenaline (NA) plasma levels were examined in 18 healthy volunteers on 2 consecutive days after a single treatment with either lormetazepam (0.06 mg/kg) (LMZ group), flunitrazepam (0.03 mg/kg) (FNZ group) or placebo (PLA group) in combination with the benzodiazepine (BZ) antagonist Ro 15-1788 (0
Ro 15-1788, a benzodiazepine antagonist, has been advocated as a new treatment for hepatic encephalopathy. This drug is extensively metabolized by the liver in normal subjects. In the present study, we examined Ro 15-1 788 disposition in eight healthy controls (Group I), eight cirrhotic patients wit